Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Chemical characterization of diaspirin cross-linked hemoglobin polymerized with poly(ethylene glycol).

Buehler PW, Boykins RA, Norris S, Alayash AI.

Anal Chem. 2006 Jul 1;78(13):4634-41.

PMID:
16808476
2.
3.

Site-specific modifications and toxicity of blood substitutes. The case of diaspirin cross-linked hemoglobin.

D'Agnillo F, Alayash AI.

Adv Drug Deliv Rev. 2000 Feb 28;40(3):199-212. Review.

PMID:
10837790
4.

Artificial O2 carriers: status in 2005.

Spahn DR, Kocian R.

Curr Pharm Des. 2005;11(31):4099-114. Review.

PMID:
16378514
5.

Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase.

Fontana A, Spolaore B, Mero A, Veronese FM.

Adv Drug Deliv Rev. 2008 Jan 3;60(1):13-28. Epub 2007 Aug 16. Review.

PMID:
17916398
6.

Safety and efficacy of o-raffinose cross-linked human hemoglobin (Hemolink) in cardiac surgery.

Cheng DC.

Can J Anaesth. 2001 Apr;48(4 Suppl):S41-8. Review.

PMID:
11336436
7.

HBOC vasoactivity: interplay between nitric oxide scavenging and capacity to generate bioactive nitric oxide species.

Cabrales P, Friedman JM.

Antioxid Redox Signal. 2013 Jun 10;18(17):2284-97. doi: 10.1089/ars.2012.5099. Epub 2013 Feb 12. Review.

8.

Toxicities of hemoglobin solutions: in search of in-vitro and in-vivo model systems.

Buehler PW, Alayash AI.

Transfusion. 2004 Oct;44(10):1516-30. Review.

PMID:
15383027
9.

[Chemical modification of proteins with polyethylene glycol (PEG)].

Kodera Y, Furukawa M, Inada Y.

Tanpakushitsu Kakusan Koso. 1992 Feb;37(3 Suppl):400-9. Review. Japanese. No abstract available.

PMID:
1549718
10.

Comparison of the Pharmacokinetic Properties of Hemoglobin-Based Oxygen Carriers.

Taguchi K, Yamasaki K, Maruyama T, Otagiri M.

J Funct Biomater. 2017 Mar 18;8(1). pii: E11. doi: 10.3390/jfb8010011. Review.

Supplemental Content

Support Center